Invivo Therapeutics Holdings Corp (NVIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVIV | ABT | MDT | SYK | BSX |
| Company | Invivo Therapeutics Holdings Corp | Abbott Laboratories | Medtronic Inc | Stryker Corp | Boston Scientific Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 0.4081 | 115.49 | 88.69 | 365.64 | 83.41 |
| High | 0.4090 | 115.66 | 89.94 | 366.70 | 84.89 |
| Low | 0.3010 | 113.25 | 88.55 | 362.62 | 83.33 |
| Last | 0.3207 | 114.15 | 89.47 | 365.05 | 83.71 |
| Change | -0.1673 | -0.73 | +1.34 | +3.69 | +1.14 |
| % Change | -34.28% | -0.64% | +1.52% | +1.02% | +1.38% |
| Volume | 1,885,600 | 8,144,000 | 9,374,600 | 993,900 | 7,860,600 |
| 20-Day Average Volume | 11,541,605 | 4,376,605 | 6,462,765 | 1,113,750 | 5,037,470 |
| Previous Close | 0.4880 | 114.88 | 88.13 | 361.36 | 82.57 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5823 | 114.68 | 89.35 | 361.14 | 81.71 |
| 20-Day Raw Stochastic | 11.92% | 41.39% | 52.58% | 67.06% | 81.45% |
| 20-Day Relative Strength | 37.35% | 54.85% | 60.11% | 61.10% | 65.36% |
| Weighted Alpha | -67.27 | +15.73 | +14.59 | +28.04 | +57.28 |
| Today's Opinion | 100% Sell | 72% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 72% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 64% Sell | 40% Buy | 24% Buy | 32% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +44.46% since 02/05/24 | -2.29% since 09/12/24 | -0.59% since 09/12/24 | -0.74% since 09/12/24 | -0.14% since 09/12/24 |
| Low | 0.3010 on 02/12/24 | 113.25 on 09/19/24 | 87.67 on 09/18/24 | 359.66 on 09/18/24 | 81.54 on 09/17/24 |
| High | 1.0500 on 02/06/24 | 118.54 on 09/17/24 | 90.52 on 09/13/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 |
| 1-Month | |||||
| %Chg | -58.69% since 01/12/24 | +2.01% since 08/19/24 | +5.48% since 08/19/24 | +7.03% since 08/19/24 | +6.39% since 08/19/24 |
| Low | 0.2220 on 02/05/24 | 110.33 on 08/20/24 | 83.28 on 08/20/24 | 340.96 on 08/20/24 | 78.08 on 08/20/24 |
| High | 1.0500 on 02/06/24 | 118.54 on 09/17/24 | 91.49 on 09/04/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 |
| 3-Month | |||||
| %Chg | -57.24% since 11/10/23 | +9.77% since 06/18/24 | +12.19% since 06/18/24 | +4.70% since 06/18/24 | +9.70% since 06/18/24 |
| Low | 0.2220 on 02/05/24 | 99.71 on 07/18/24 | 75.96 on 07/09/24 | 314.93 on 08/05/24 | 71.88 on 08/05/24 |
| High | 1.0500 on 02/06/24 | 118.54 on 09/17/24 | 91.49 on 09/04/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 |
| 6-Month | |||||
| %Chg | -74.75% since 08/11/23 | +0.87% since 03/19/24 | +6.37% since 03/19/24 | +2.29% since 03/19/24 | +23.48% since 03/19/24 |
| Low | 0.2220 on 02/05/24 | 99.71 on 07/18/24 | 75.96 on 07/09/24 | 314.93 on 08/05/24 | 66.80 on 04/22/24 |
| High | 1.3099 on 08/25/23 | 118.54 on 09/17/24 | 91.49 on 09/04/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 996 | 199,849,152 | 113,006,448 | 137,660,096 | 121,138,112 |
| Shares Outstanding, K | 3,105 | 1,739,634 | 1,282,270 | 380,950 | 1,467,096 |
| Annual Sales | 0 | 40,109,000,000 | 32,364,000,000 | 20,498,000,000 | 14,240,000,000 |
| Annual Net Income | -10,490,000 | 5,723,000,000 | 3,677,000,000 | 3,165,000,000 | 1,591,000,000 |
| Last Quarter Sales | 0 | 10,377,000,000 | 7,915,000,000 | 5,422,000,000 | 4,120,000,000 |
| Last Quarter Net Income | -2,700,000 | 1,302,000,000 | 1,043,000,000 | 825,000,000 | 324,000,000 |
| 60-Month Beta | 0.65 | 0.72 | 0.84 | 0.91 | 0.79 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.87 on 11/08/23 | 1.14 on 07/18/24 | 1.23 on 08/20/24 | 2.81 on 07/30/24 | 0.62 on 07/24/24 |
| Latest Earnings Date | 02/14/24 | 10/16/24 | 08/20/24 | 11/07/24 | 10/24/24 |
| Most Recent Dividend | N/A | 0.550 on 07/15/24 | 0.700 on 06/27/24 | 0.800 on 06/28/24 | N/A |
| Next Ex-Dividends Date | N/A | 07/15/24 | 09/27/24 | 06/28/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.55 | 16.91 | 32.41 | 37.00 |